RecruitingNot Applicable

Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction

Turkey (Türkiye)44 participantsStarted 2026-03-26

Plain-language summary

The aim of this study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) added to conventional neurological rehabilitation on heart rate variability (HRV), quality of life, upper extremity muscle strength and autonomic symptoms in patients with stroke.

Who can participate

Age range

35 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants aged 35-80 years admitted to the Afyonkarahisar Health Sciences University Hospital Physical Medicine and Rehabilitation Unit for neurological rehabilitation after stroke * Participants with a history of stroke of at least 3 months * Neurologically and medically stable participants willing to participate regularly in the study * Participants capable of following commands Exclusion Criteria: * Serious cardiac disease, uncontrolled hypertension * Epilepsy or history of antiepileptic drug use * Intracranial metallic implants * Inner ear implants * Malignancy * Active infection * Skin infection or open wound in the intervention area * Brain lesions or medications that may alter the seizure threshold * Increased intracranial pressure * Uncontrolled migraine * Fracture or surgery on the hemiplegic side within the last 6 months * Pregnancy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from Baseline in Heart Rate Variability (HRV) Assessment at the 4th week

Timeframe: Baseline and after final rTMS session( at 4th week)

Trial details

NCT IDNCT07482501

SponsorAfyonkarahisar Health Sciences University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-15

Contact for this trial

ülkü demir

5423541114 ulkudemir_44@hotmail.com

View on ClinicalTrials.gov More Stroke trials

Who can participate

Age range

35 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.